施万细胞与外周癌症之间的相互作用:癌症进展中的机制和治疗点
Glia
|May 10, 2025
概括
施万细胞 (SCs) 显著影响癌症的进展,影响各种癌症的瘤生长,入侵和治疗抵抗力. 对SC-癌症关系的进一步研究可能会开启新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 神经科学是一个神经科学.
- 瘤微环境研究 研究
背景情况:
- 癌症是一种复杂的疾病,由不受控制的细胞增殖和转移驱动.
- 瘤微环境 (TME) 包括各种影响癌症进展的细胞.
- Schwann 细胞 (SCs),是外周神经系统的质细胞,越来越多地被认为是TME的关键参与者.
研究的目的:
- 审查施万细胞 (SCs) 在癌症发育和进展中的多方面的作用.
- 专注于SCs对八种外围癌症的影响,包括胰腺癌,肺癌和结直肠癌.
- 探索SCs与癌症相关疼痛之间的关联,以及它们的治疗潜力.
主要方法:
- 文献综述综合了现有关于癌症中施万细胞的研究.
- 分析SCs在瘤生长,上皮-介质细胞过渡,围神经入侵和化疗耐药性方面的作用.
- 检查癌症治疗中使用SCs的先进技术和临床策略.
主要成果:
- 施万细胞 (SCs) 积极促进瘤生长,上皮细胞-介质细胞过渡和围神经侵入.
- SCs与化疗耐药性和癌症相关的疼痛有关,影响患者的预后和生活质量.
- SCs显示出治疗潜力,正在进行的研究探索新的临床策略.
结论:
- 施万细胞 (SCs) 在各种外围癌症的进展中发挥着重要而复杂的作用.
- 了解SC癌症关系的分子机制对于开发有效的治疗方法至关重要.
- 针对SC或利用其属性为改善癌症管理和患者结果提供了有希望的途径.
更多相关视频
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.